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ive-year experience of vertebral osteomyelitis treatment at
ameda Medical Center, Japan
. Hase ∗, K. Tochitani, K. Muranaka, Y. Uwamino, M. Sogi, H.
itazono, Y. Otsuka, N. Hosokawa
Kameda Medical Ceter, Kamogawa, Chiba, Japan
Background: Vertebral osteomyelitis (VO) is caused by vari-
us pathogens. Although identifying the causative organism before
tarting the treatment is important, it is not always possible, thus
mpirical treatment is sometimes necessary.
Methods: We collected the clinical information of 76 patients
ith VO for the past ﬁve years from our electronic medical record
ystem. Causative pathogen, mode of detection, site of infection,
reatment duration, and outcome were reviewed retrospectively.
n addition, we categorized all the patients into three groups:
ommunity acquired (CAVO), healthcare-associated (HCAVO), and
ospital-acquired (HAVO), and evaluated the differences in the
rganisms.
Results: VO was clinically diagnosed in 76 patients. Causative
rganism was detected in 56 (73.6%). Most organisms were pyo-
enic except for one case of tuberculosis. Of these 55 patients,
8 (32.7%) had Staphylococcus aureus (12 methicillin-susceptible
taphylococcus aureus [MSSA] and 6 methicillin-resistant Staphylo-
occus aureus [MRSA]); 5 (9.1%) Coagulase-Negative Staphylococci
CNS); 7 (12.7%)-Streptococci; 8 (14.5%)-Streptococci; 9 (16.4%)
nterobactericiae; 3 (5.5%) Candida spp.; and 5 (9.1%) others. In
8 (87.2%) of the 55 patients with organism-proven VO, organ-
sms were detected by blood culture. Twenty-eight (58.3%) of
he 48 patients had persistent bacteremia, which is often seen
ith CNS and S. aureus. Infective endocarditis was conﬁrmed in
(12.2%) patients. Biopsy was performed in 30 (40.5%) patients
nd organisms were cultured in 16 (53.3%) patients. Thirty-ﬁve
47.3%) patients were regarded as CAVO, 16 (21.6%) HCAVO, and 23
31.1%)HAVO. Commonorganisms for CAVOwereMSSA (26.0%),-
treptococci (26.0%), and-Streptococci (22.2%). NeitherMRSAnor
andida spp. caused CAVO. Lower lumbar vertebrae were the most
requently infected area. Average duration of parenteral antibiotic
reatment was 49 days. Thirty-eight (50%) patients were followed
or at least half a year and only 2 (5.2%) patients were suspected to
ave relapsed.
Conclusion: Patients with VO are likely to have bacteremia;
hus, blood culture is a useful tool to ﬁnd the causative organism.
f empirical treatment is necessary, it should be tailored according
o the type of VO and local epidemiological data.
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Bacteraemia caused by genus Oligella
V. Hasseltvedt1,∗, D. Caugant2
1 Sykehuset Innlandet Trust, Lillehammer, Norway
2 Norwegian Public Health Institute, Oslo, Norway
Background: The Department of Medical Microbiology, Lille-
hammerhas around420000analyses yearly.Wecover the counties
of Oppland and Hedmark, analysing specimens from hospitals as
well as from general practitioners and others. The counties of Opp-
land and Hedmark are located – bordering each other - in the
Central Eastern part of Norway. The area of our counties equals
53200 square kilometres i.e. approx. that of Denmark (43094
square kilometres). The population is 371500 (data as of the end of
2010).
Genus Oligella comprises small, non-fermentative, non-motile,
non-sporeforming Gram-negative rods. Oligella comprises two
species, namelyOligella urethralis, formerlyMoraxellaurethralis
and Oligella ureolytica, formerly CDC group IVe. Moraxella ure-
thralis has most frequently been associated with urinary tract
infections. In MEDLINE (as of September 29, 2011) there were
26 “hits” when it comes to peer-reviewed articles concerning
“Oligella” and two for Oligella and sepsis. We here describe what
maybe theﬁrstdocumentedNorwegiancaseofbacteraemiacaused
by Oligella.
Methods: An 81 year old male was admitted to Sykehuset
Innlandet Hospital in April 2011. From blood cultures, taken on
admission, Gram-negative rod-shaped bacteria were grown on
blood and chocolate agar. NIPH - performed reference testing,
including 16SrRNA sequencing.
Results: Growth conditions etc.
Haemolysis: None
Growth – blood agar - aerobic conditions: 3+
Growth – chocolate agar - aerobic conditions: 3+
Growth – lactose agar - aerobic conditions: None
Corrosion: Negative
Motility 22 deg. C None
Motility 30 deg. C None
Biochemical and other reactions:
Mannitol: Negative
Nitrate reduction: Negative
Catalase: Positive
Oxydase: Positive
OF Glucose: No growth
Susceptibility:
Vancomycin 5 ug: Resistant
Sequencing: A 524 base pair fragment of the 16SrRNA gene was
sequenced. It showed 99% homology with Oligella urethralis, hence
the bacterium belongs to genus Oligella.
Conclusion: Previously our department has detected cul-
tures positive for Anaerobiospririllum succiniciproducens, Dial-
ister sporosintes, Granulicatella adjacens, Actinobaculum schalii,
Clostridium scindens, Globicatella sulphidifaciens, Eggertella lenta,
Leptotrichia trevisianii, Weeksella virosa and Bulleidia moorei –
among others. A medium-sized laboratory often does not have
the equipment to perform more sophisticated analyses. Therefore
some samples must be referred to central reference laboratories.
